World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
54
Citations
11104
World Ranking
2321
National Ranking
1144

Lingeng Lu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Lingeng Lu sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 167 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Lingeng Lu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Lingeng Lu sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 54 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Lingeng Lu is affiliated with Yale University in the United States. Their research activity spans key areas in medicine and biochemistry, genetics and molecular biology, with notable focus on molecular biology, oncology, cancer research, immunology, and obstetrics and gynecology.

The main subjects addressed in Lingeng Lu's scholarly work include cancer-related molecular mechanisms research, cancer immunotherapy and biomarkers, cancer risks and factors, epigenetics and DNA methylation, endometrial and cervical cancer treatments, RNA modifications and cancer, and immunotherapy and immune responses.

Frequent coauthors collaborating with Lingeng Lu include:

  • Harvey A. Risch
  • Herbert Yu
  • Rui Han
  • Caroline H. Johnson
  • Sajid Khan

Lingeng Lu has published extensively in several venues, with the most common outlets being:

  • Cancers
  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Journal of Cancer
  • International Immunopharmacology
  • BMC Cancer

Recent notable papers authored or coauthored by Lingeng Lu include:

  • "Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma" (2021, European Journal of Cancer)
  • "Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer" (2020, International Journal of Cancer)
  • "Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors" (2020, International Immunopharmacology)
  • "Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study" (2021, BMC Cancer)
  • "tRFtarget: a database for transfer RNA-derived fragment targets" (2020, Nucleic Acids Research)

Lingeng Lu's work links molecular and clinical insights across cancer biology, immunotherapy, and genetic risk factors. Their ongoing contributions to oncology and molecular biology enhance understanding of cancer mechanisms, immune responses, and therapeutic biomarkers.

Best Publications

  • The imprinted H19 lncRNA antagonizes let-7 microRNAs.

    Amanda N. Kallen;Xiao-Bo Zhou;Xiao-Bo Zhou;Jie Xu;Chong Qiao;Chong Qiao

  • Type I and II Endometrial Cancers: Have They Different Risk Factors?

    Veronica Wendy Setiawan;Hannah P. Yang;Malcolm C. Pike;Malcolm C. Pike;Susan E. McCann;Susan E. McCann

  • High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1

    Biyun Qian;Dionyssios Katsaros;Lingeng Lu;Mario Preti

  • Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.

    Lingeng Lu;Dionyssios Katsaros;Irene A. Rigault de la Longrais;Olga Sochirca

  • Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

    Erica J Childs;Evelina Mocci;Daniele Campa;Daniele Campa;Paige M Bracci

  • Identification of nine new susceptibility loci for endometrial cancer

    Tracy A. O'Mara;Dylan M. Glubb;Frédéric Amant;Daniela Annibali

  • Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

    Alison P. Klein;Brian M. Wolpin;Harvey A. Risch;Rachael Z. Stolzenberg-Solomon

  • Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.

    L Yan;J Zhou;Y Gao;S Ghazal

  • H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase

    Jichun Zhou;Lihua Yang;Tianyu Zhong;Martin Mueller

  • ABO Blood Group, Helicobacter pylori Seropositivity, and Risk of Pancreatic Cancer: A Case–Control Study

    Harvey A. Risch;Herbert Yu;Lingeng Lu;Mark S. Kidd

  • Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer

    Lingeng Lu;Guangjian Zhu;Chong Zhang;Qian Deng;Qian Deng

  • A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk

    Elena Ratner;Lingeng Lu;Marta Boeke;Rachel Barnett

  • Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II.

    Lingeng Lu;Dionyssios Katsaros;Khvaramze Shaverdashvili;Biyun Qian;Biyun Qian

  • Metformin alters DNA methylation genome-wide via the H19/SAHH axis

    T. Zhong;Y. Men;Y. Men;L. Lu;T. Geng;T. Geng

  • IGF-I in epithelial ovarian cancer and its role in disease progression.

    Jane Brokaw;Dionyssios Katsaros;Andrew Wiley;Lingeng Lu

  • Genome-Wide Association Study of Alcohol Dependence Implicates KIAA0040 on Chromosome 1q

    Lingjun Zuo;Joel Gelernter;Clarence K. Zhang;Hongyu Zhao

  • Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1

    Hongmei Zeng;Melinda L. Irwin;Lingeng Lu;Harvey Risch

  • Characterization of large structural genetic mosaicism in human autosomes

    Mitchell J. Machiela;Weiyin Zhou;Joshua N. Sampson;Michael C. Dean

  • Autoinducer-2–like Activity Associated with Foods and Its Interaction with Food Additives

    Lingeng Lu;Michael E. Hume;Michael E. Hume;Suresh D. Pillai

  • ABO Blood Group and Risk of Pancreatic Cancer: A Study in Shanghai and Meta-Analysis

    Harvey A. Risch;Lingeng Lu;Jing Wang;Wei Zhang

Frequent Co-Authors

Harvey A. Risch
Harvey A. Risch Yale University
Dionyssios Katsaros
Dionyssios Katsaros University of Turin
Immaculata De Vivo
Immaculata De Vivo Harvard University
Melinda L. Irwin
Melinda L. Irwin Yale University
Jennifer A. Doherty
Jennifer A. Doherty University of Utah
Xiao-Ou Shu
Xiao-Ou Shu Vanderbilt University Medical Center
Graham G. Giles
Graham G. Giles University of Melbourne
Christine M. Friedenreich
Christine M. Friedenreich Alberta Health Services
Jolanta Lissowska
Jolanta Lissowska Maria Sklodowska-Curie National Research Institute of Oncology
Amanda B. Spurdle
Amanda B. Spurdle QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Molecular Biology often pursue related fields in healthcare and the life sciences, many of which offer flexible online study options. For example, numerous online bsn programs for non nurses provide an accelerated path to nursing careers for those with a science background.

There are also efficient transition opportunities for registered nurses seeking advancement. Programs like rn to bsn online can be completed in as little as six months, allowing RNs to boost their credentials conveniently.

For graduates interested in advanced clinical roles, learning how to become a np (nurse practitioner) highlights several possible educational paths and timelines, which can be surprisingly short with the right prior qualifications.

If psychiatry or mental health interests you, reviewing a dnp psychiatric nurse practitioner salary breakdown by state offers insight into career potential and earning prospects in this specialized area.

Best Scientists Citing Lingeng Lu

Trending Scientists

Recently Published Articles